Locations
Conditions
Treatments
Institutions
Resources
For researchers
About us
Clinical trials
Open-label Single-Center Study to Evaluate the Safety and Efficacy of Combining Rituximab and AB-101 in B-cell Associated Autoimmune Diseases.
Apply
Rituximab & AB-101
Open-label Single-Center Study to Evaluate the Safety and Efficacy of Combining Rituximab and AB-101 in B-cell Associated Autoimmune Diseases.
Basic information
Step 1/5
Provide your basic information
Age
ZIP code
Back
Next step